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Abstract
Background:  Chagas' disease may cause left ventricular diastolic dysfunction and its early
detection in asymptomatic patients would allow to stratify the risk and to optimize medical
treatment. The aim of this study is to investigate if transmitral Doppler flow can detect early
abnormalities of the diastolic left ventricular function in patients during the indeterminate phase of
Chagas' disease, in which the electrocardiogram (ECG), chest x-ray and 2-D echocardiogram (2D-
echo) are normal.
Methods: a group of 54 patients with Chagas' disease was studied and compared to a control
group of 27 subjects of similar age. All were assessed with an ECG, chest X-ray, 2-D echo, and
transmitral Doppler flow.
Results: both groups had similar values in the 2D-echo. In patients with Chagas' disease, the
transmitral Doppler showed a higher peak A velocity (control group: 0.44 m/sec, Chagas group:
0.55 m/sec, p = 0.001), a lower E/A ratio (control group: 1.45, Chagas group: 1.22, p < 0.05), and
a lengthening of the deceleration time of early diastolic filling (control: 138.7 ± 26.8 msec, Chagas
group: 167.9 ± 34.6 msec, p = 001), thus revealing an early disorder of the diastolic left ventricular
function in patients with Chagas' disease.
Conclusion: in patients with Chagas' disease who are in the indeterminate phase, transmitral
Doppler flow allowed to identify early abnormalities of the left ventricular diastolic function, which
provide useful clinical information for prognostic stratification and treatment.
Background
Chagas' disease is a protozoan infestation caused by
Trypanosoma cruzi and is one of the most relevant public
health problems and a major cause of heart failure and
death in Latin America. More than 100 million people are
estimated to be infected and at risk of acquiring the dis-
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ease and more than 18 million have already acquired it,
and it causes 50.000 deaths per year, especially among the
poorer countries [1]. As a consequence of migrations from
Latin America, a globalization of the disease is under way,
and there currently are thousands of infected Latin Amer-
icans residing in the US and Europe [2,3]. In Argentina,
20% of the 2 million infected people develop Chagas' dis-
ease, which causes 5.000 – 6.000 deaths per year.
Most infested patients are in the indeterminate phase of
the disease, defined as the phase without ECG, X-ray or
2D-echo abnormalities and without signs of clinical car-
diac involvement [4]; One third of these patients will
eventually develop chronic Chagas cardiomyopathy [5].
During this indeterminate stage, the early detection of
myocardial damage may be important for an individual
approach to risk stratification. Among the available meth-
ods, transmitral Doppler flow may be very useful for the
quantitative analysis of the left ventricular diastolic func-
tion.
The objective of this study was to assess the usefulness of
transmitral Doppler flow to detect early left ventricular
diastolic function abnormalities in patients during the
indeterminate stage of Chagas' disease, when the ECG,
chest X-ray and 2- echo are normal.
Methods
Population
We carried out a cross-sectional study of the population,
including data collected from February 2004 until Febru-
ary 2006, from 81 subjects (46 men and 35 women) aged
41.4 ± 5.6 years (range, 30–50 years), whose ECG, chest
X-ray and 2-D echo were normal. Subjects were divided
into 2 groups: a Chagas group (54 patients with the inde-
terminate phase of Chagas' disease) and a control group
(27 normal subjects). All patients were referred from the
Instituto Nacional de Parasitología "Dr. Mario Fatala
Chaben", in Buenos Aires. After patients were explained
the goal of this investigation, all of them signed the
informed consent.
The study was approved by our Institutional Review Board
and the Investigation Health Council of the Secretary of
Health of the Government of the City of Buenos Aires.
Apical four-chamber view of the left ventricle and Doppler transmitral flow velocity Figure 1
Apical four-chamber view of the left ventricle and Doppler transmitral flow velocity. Left: normal pattern. Right: abnormal pat-
tern of a patient with Chagas' disease. LV: left ventricle, LA: left atrium, E: peak early diastolic velocity, A: peak late diastolic 
velocity, DT: deceleration time of the early diastolic flow.Cardiovascular Ultrasound 2006, 4:18 http://www.cardiovascularultrasound.com/content/4/1/18
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All patients with Chagas' disease, 25 men and 29 women,
aged 41.7 ± 5.7 years (range 30–50 years), had a history of
residence in an endemic zone and were asymptomatic.
Exclusion criteria were: coronary artery disease, valvular,
myocardial or pericardial disease, congenital heart dis-
ease, clinical evidence of heart failure or asymptomatic
systolic dysfunction (ejection fraction < 50%), hyperten-
sion, diabetes mellitus, anemia, asthma, chronic obstruc-
tive pulmonary disease, thyroid dysfunction, renal failure,
pregnancy, a history of alcohol intake or other disorders
that could potentially cause cardiac disease.
Left ventricular (LV) dilatation was a reason for exclusion
of patients when the diastolic diameter of the LV exceeded
3.2 cm/m2, and similarly for systolic dysfunction when
shortening fraction was below 28%.
Prior to selection, patients underwent an anamnesis,
physical exam, ECG, chest X-ray, cardiac Doppler-echo
and laboratory blood tests (complete blood count, sedi-
mentation rate, blood urea nitrogen, creatinine, glycemia,
ionogram, T3, T4, TSH and serology for Chagas' disease).
Immunodiagnostic tests were considered reactive for Cha-
gas' disease in the following cases: enzymatic assay >
0.200, quantitative indirect hemagglutination > 1:32,
quantitative indirect immunofluorescence > 1:32.
Patients in whom 2 of these 3 tests were positive for
Trypanosoma cruzi, were considered to have Chagas' dis-
ease.
Control group
The control group consisted of 27 healthy volunteers, 21
men and 6 women, with a mean age of 40.5 ± 5.2 years
(range 30–48 years), no history of endemic environment
for South American trypanosomiasis, negative serology
for Chagas' disease, normal physical exam, ECG, chest X-
ray and Doppler-echo, and with similar exclusion criteria.
Two-dimensional echocardiography
Doppler-echocardiograms were performed with Philips
ultrasound equipment and a 2.5 MHz transducer. Par-
asternal (long- and short-axis views) and apical views
were obtained (four-chamber, two-chamber and apical
long-axis views).
All studies were recorded on videotape for their deferred
analysis. Echocardiograms were reviewed by 2 experi-
enced readers who were not aware of the serum test results
for Chagas' disease.
The M-mode was derived from the short-axis view at the
papillary muscle level, and the following parameters were
measured according to the American Society of Echocardi-
ography guidelines [6]: LV end diastolic diameter
(LVEDd), LV end systolic diameter (LVESd), septal and
posterior wall thickness, and antero-posterior diameter of
the left atrium, measured from the left parasternal long-
axis. The LV shortening fraction was calculated with the
following formula: [(LVEDd-LVESd)/LVEDd] × 100.
The LV mass index was calculated according to Devereux's
formula [7], and hypertrophy was defined as a value > 134
g/m2 for men and > 110 g/m2 for women.
Table 1: Clinical, echocardiographic and transmitral Doppler findings.
Control (n = 27) Chagas (n = 54) p
Age (y) 40.5 ± 5.2 41.7 ± 5.7 NS
Female, n (%) 6 (22,2) 29 (53,7) 0.01
Body mass index (Kg/m2) 26.04 ± 3.47 27.30 ± 4.36 NS
LVEDd (mm) 49.3 ± 4.4 48.6 ± 4.5 NS
LVESd (mm) 28.6 ± 4.7 29.3 ± 4.3 NS
LVEDd index (mm/m2) 25.83 ± 3.10 26.64 ± 2.50 NS
Fractional shortening (%) 42.0 ± 6.9 39.8 ± 5.9 NS
IVS (mm) 9.6 ± 1.35 9.9 ± 1.6 NS
PW (mm) 7.59 ± 1.08 7.96 ± 0.84 NS
LV mass index (g/m2) 89.25 ± 16.97 95.78 ± 18.38 NS
LA (mm) 35.2 ± 3.5 34.8 ± 4.2 NS
Aortic root (mm) 31.3 ± 2.9 31.3 ± 3.2 NS
E wave (m/sec) 0.65 (0.58–0.73) 0.71 (0.58–0.79) NS
A wave (m/sec) 0.44 (0.41–0.53) 0.55 (0.46–0.64) 0.001
E/A ratio 1.45 (1.19–1.57) 1.22 (0.99–1.52) 0.05
DT (msec) 138.7 ± 26.8 167.9 ± 34.6 0.001
LVEDd: left ventricular end diastolic dimension, LVESd: left ventricular end systolic dimension, IVS: interventricular septum, PW: posterior wall, LA: 
left atrial dimension, LV: left ventricle, A: peak early diastolic velocity, E: peak late diastolic velocity, DT: early filling deceleration time.Cardiovascular Ultrasound 2006, 4:18 http://www.cardiovascularultrasound.com/content/4/1/18
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Transmitral flow velocity
Transmitral flow velocity was used to quantify left ven-
tricular diastolic function (Figure 1). The sample volume
was placed at the tip of the mitral valve leaflets in the four-
chamber apical view. Peak early diastolic velocity (E-
wave), peak late diastolic velocity (A-wave), E/A ratio and
early filling deceleration time were measured [8].
All studies were recorded on videotape and later analyzed
by two independent investigators who were unaware of
the patients' clinical data. For each quantitative parame-
ter, three consecutive beats were averaged.
Statistical analysis
Quantitative data that were normally distributed were
expressed as means ± standard deviation, and data with a
non-gaussian distribution were expressed as medians
(inter-quartile interval).
The comparison of inter-group quantitative variables was
performed with a t-test in the case of variables with a nor-
mal distribution, and with the Wilcoxon Rank Sum Test in
the case of variables with a non-normal distribution.
In 20 subjects, the intraclass correlation coefficient was
used [9] to measure the intraobserver agreement between
two measurements, and the interobserver agreement
between the average of the intraobserver measurements
and one interobserver measurement. A p value < 0.05 was
considered to be statistically significant.
Statistical analyses were performed with the Statistix 7.0
software for Windows.
Results
The clinical and echocardiographic characteristics of
patients in the control and Chagas groups are summarized
in Table 1. No statistically significant differences were
found in age (control: 40.5 ± 5.2 years, Chagas group:
Late diastolic filling (A wave) values on transmitral Doppler in healthy subjects and patients with Chagas' disease Figure 2
Late diastolic filling (A wave) values on transmitral Doppler in healthy subjects and patients with Chagas' disease. Box plot dis-
playing median and interquartile range: solid circles indicate means.Cardiovascular Ultrasound 2006, 4:18 http://www.cardiovascularultrasound.com/content/4/1/18
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41.7 ± 5.7 years, p = NS), or body mass index (control:
26.04 ± 3.47 kg/m2, Chagas group: 27.30 ± 4.36 kg/m2,
p = NS). Among Chagas patients, female sex prevailed
(control 22.2%, Chagas group: 53.7%, p = 0.007).
Both groups had normal dimensions, thickness and ven-
tricular function, and no wall motion abnormalities were
detected.
By contrast, a statistically significant difference was seen
between the two groups (Table 2 and Figures 2, 3, 4) in
transmitral A peak velocity (control 0.44 cm/sec, Chagas
group: 0.55 cm/sec, p = 0.001), in the mitral E/A ratio
(control 1.45, Chagas group: 1.22, p < 0.05), and in the
deceleration time of the early diastolic filling (control:
138.7 ± 26.8 msec, Chagas group: 167.9 ± 34.6 msec, p =
001), thus demonstrating an early disorder of the left ven-
tricular diastolic function in patients with Chagas' disease.
Intraobserver and interobserver agreement of transmitral 
Doppler flow measurements
Intraobserver agreement measured by the intraclass corre-
lation coefficient varied between 0.995 for the velocities
of both ventricles and 0.882 for the time measurements.
Interobserver agreement varied between 0.993 for veloci-
ties and 0.832 for the time measurements.
Discussion
Chagas' disease affects mainly the heart and may cause
arrhythmias, systemic embolism, heart failure and sudden
E/A ratio of the transmitral Doppler values in healthy subjects and patients with Chagas' disease Figure 3
E/A ratio of the transmitral Doppler values in healthy subjects and patients with Chagas' disease. Box plot displaying median 
and interquartile range: solid circles indicate means.Cardiovascular Ultrasound 2006, 4:18 http://www.cardiovascularultrasound.com/content/4/1/18
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arrhythmic death. It consists of three phases: acute, inde-
terminate and chronic. The acute  phase lasts 1 to 2
months, is generally mild and with few symptoms, and
hence in most cases goes unnoticed; occasionally, espe-
cially in children, it may be fatal. The indeterminate phase,
also called pre-clinical or latent phase, begins with the
remission of the acute phase and ends with the first clini-
cal manifestation of Chagas cardiomyopathy; it is gener-
ally benign but may develop serious, potentially lethal
complications [10] and is characterized by a long period
(20 to 30 years) during which the patient has positive
serology but is asymptomatic, with normal ECG, chest X-
ray and 2-D echo. One third of such patients progress to
the chronic stage, developing chronic Chagas cardiomyop-
athy (ECG and echocardiographic alterations and heart
failure).
When the parasite enters the human body, an inflamma-
tory reaction takes place in the heart or the gastrointesti-
nal system. As a consequence, an immune reaction
ensues: when appropriate, it controls the parasitemia and
the patient remains in the indeterminate phase. If, how-
ever, the immune reaction is inappropriate, parasitemia
persists, inflammation progresses and with time (2 o 3
decades), there is damage to the heart, the digestive sys-
tem or both.
Although most of the follow-up studies show that prog-
nosis of patients in the indeterminate phase is good, every
year 3% of them progress towards the chronic phase [5],
which explains why, at 10 years, 30% of patients develop
ECG or echocardiographic abnormalities. Additionally,
sudden death may occur as the first manifestation of the
disease in asymptomatic patients [11]. Therefore, an early
identification of the signs of myocardial damage may be
useful for risk stratification and the selection of an early
medical treatment.
Barros et al [12] were the first authors to detect early LV
diastolic dysfunction in patients with the indeterminate
phase of Chagas' disease, demonstrated with transmitral
Doppler flow, a lengthening of the deceleration time and
isovolumic relaxation time, without changes in early and
late ventricular filling velocities, but in our study we saw
Deceleration time of the early diastolic filling values on transmitral Doppler in healthy subjects and patients with Chagas' dis- ease Figure 4
Deceleration time of the early diastolic filling values on transmitral Doppler in healthy subjects and patients with Chagas' dis-
ease. Box plot displaying median and interquartile range: solid circles indicate means.Cardiovascular Ultrasound 2006, 4:18 http://www.cardiovascularultrasound.com/content/4/1/18
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an increase in peak A velocity, a decrease in E/A ratio and
an increase in the deceleration time of early diastolic fill-
ing, hence left ventricular diastolic dysfunction may be
the earliest manifestation of heart disease and may occur
in the absence of abnormalities in the overall LV systolic
function; this might indicate a less affected population,
which initially demonstrates only diastolic abnormalities.
Pathology data (biopsies and necropsies) have shown
[13,14] early signs of myocardial damage with histologi-
cal and ultrastructural changes in 30% to 60% of patients
with Chagas disease and no evidence of heart disease,
such as hypertrophy, degeneration of myocardial fibers,
interstitial edema, fibrosis and an inflammatory infiltrate.
These alterations are not serious enough to cause a distur-
bance in the conduction system or the contractile function
which could be seen by ECG or 2D-echo, but they could
be observed by using methods such as DTI that enable the
evaluation of regional cardiac function.
This preclinical myocardial damage observed during the
indeterminate phase of the disease is not an inactive stage
but is progressive, and the progression continues from the
destruction of myocardial cells until their replacement by
fibrosis [4], which may be shown by cardiovascular mag-
netic resonance in up to 20% of patients who are in the
indeterminate phase of Chagas' disease [15].
Myocarditis in Chagas' disease initially causes low grade
focal damage which may be detected early with transmi-
tral Doppler flow in patients with the indeterminate
phase of Chagas' disease, while a more severe damage
causes systolic myocardial dysfunction, evidenced by
morphological and functional changes in the 2D-echo,
characteristic of the chronic phase of the disease.
Conclusion
In patients who are in the indeterminate phase of Chagas'
disease, transmitral Doppler reveals early changes in left
ventricular diastolic function. This evidences of preclinical
myocardial damage and would hence allow to stratify the
risk, to optimize medical treatment and improve the qual-
ity and duration of patients' lives. Prospective longitudi-
nal cohort studies might allow to confirm the efficacy of
transmitral Doppler in the evaluation of the natural his-
tory of patients with subclinical myocardial disorders.
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